Jazz Pharmaceuticals plc Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Jazz Pharmaceuticals plc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Jazz Pharmaceuticals plc Operating Income (Loss) for the quarter ending June 30, 2024 was $199M, a 26.5% increase year-over-year.
  • Jazz Pharmaceuticals plc Operating Income (Loss) for the twelve months ending June 30, 2024 was $561M, a 1144% increase year-over-year.
  • Jazz Pharmaceuticals plc annual Operating Income (Loss) for 2023 was $579M.
  • Jazz Pharmaceuticals plc annual Operating Income (Loss) for 2022 was -$65.5M, a 138% decline from 2021.
  • Jazz Pharmaceuticals plc annual Operating Income (Loss) for 2021 was $170M, a 55% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $561M $199M +$41.8M +26.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $519M $66.2M -$59.8M -47.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $579M $122M +$386M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $193M $172M +$148M +596% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $45.1M $158M +$72.1M +84.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$27M $126M +$38.5M +44% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$65.5M -$263M -$313M -633% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $247M $24.8M -$3.61M -12.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $251M $85.5M +$155M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $95.7M $87.5M -$74.6M -46% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $170M $49.4M -$124M -71.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $294M $28.4M -$168M -85.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $462M -$69.6M -$268M -135% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $730M $162M +$352M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $378M $173M +$112M +183% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $266M $196M +$63.1M +47.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $203M $198M -$6.16M -3.01% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $209M -$190M -$323M -242% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $532M $61.2M -$124M -66.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $656M $133M -$55.7M -29.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $712M $204M +$51.1M +33.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $661M $134M +$45.9M +52.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $615M $185M +$43.9M +31.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $571M $189M +$102M +118% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $469M $153M -$11.8M -7.18% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $481M $87.8M -$48.3M -35.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $529M $141M -$24.3M -14.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $553M $86.5M -$49.8M -36.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $603M $165M -$3.69M -2.19% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $607M $136M +$15M +12.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $592M $166M +$58.9M +55.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $533M $136M +$4.72M +3.59% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $528M $169M +$15.4M +10.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $513M $121M +$4.4M +3.77% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $508M $107M -$23.3M -17.9% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $532M $132M +$73.5M +127% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $458M $153M +$79M +106% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $379M $117M +$183M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $196M $130M +$35.4M +37.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $160M $58M -$42.5M -42.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $203M $74.3M -$2.78M -3.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $205M -$66.7M -$135M -198% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $340M $94.5M +$27.1M +40.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 $313M $101M +$45.3M +81.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 $268M $77.1M +$37.6M +95.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $230M $68.2M +$32.4M +90.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $198M $67.4M +$29.7M +78.9% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $168M $55.3M +$21.6M +64.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $147M $39.4M +$5.57M +16.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $141M $35.7M +$13.1M +58.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-07
Q4 2011 $128M $37.7M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $33.7M +$19.3M +133% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $33.9M +$23.3M +220% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $22.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q3 2010 $14.4M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $10.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.